Technology Listings


Enzymatic Treatment to Increase Peripheral Nerve Regeneration

Application

Combination treatment of four enzymes to block nerve growth inhibitory molecules in peripheral nerve injury.

Key Benefits
  • Enzymes degrade all three families of growth inhibiting molecules in peripheral nerve injury.
  • Combination treatment shows synergistic, not additive effect.
Market Summary

Peripheral nerve injury can occur in a variety of ways. They can be severed or crushed during traumatic injury, or degenerate as a symptom of progressive diseases such as diabetes. Loss of peripheral nerve function can lead to poor motor control of limbs and/or abnormal pain sensations. Currently only surgical intervention exists as a treatment for peripheral nerve injury. However, full recovery of function is often not achieved, even after this treatment. Therefore, adjunct or new treatments for peripheral nerve injury are needed.

Technical Summary

Axons in peripheral nerves are capable of regeneration, but restoration of normal function following peripheral nerve injury is poor. The principle growth inhibitory molecules in the distal stumps of injured peripheral nerves are members of three groups of proteoglycans distinguished by the composition of their glycosaminoglycan (GAG) side chains. Previous studies have shown that enzymes to dissolve GAGs containing chondroitin sulfate (CSPGs) increase nerve regeneration after injury, however this regeneration is incomplete suggesting other inhibitory molecules are involved. Emory researchers have developed a combination treatment of four enzymes to target the three groups of side chains, CSPGs, heparin sulfate polysaccharides (HSPGs), and keratin sulfate polymers (KSPGs). This enzyme cocktail has shown to stimulate regeneration at rates greater than the summation of the four enzymes used separately.

Developmental Stage

In vivo nerve regeneration data in rodents is available.

Patent Information
App Type Country Serial No. Patent No. File Date Issued Date Expire Date
Utility(parent) United States 11/051,996 7,772,185 1/31/2005 8/10/2010 10/14/2025
Tech ID: 05009
Published: 5/24/2013
Category
Therapeutics

Contact
Hyeon (Sean) Kim
Licensing Associate
Emory University
hkim70@emory.edu

Inventor(s)
Arthur English
Robert McKeon
Erica Werner

Keywords
Neuroscience/Pain
Biologic